PPB - Services

Complaints, Feedback and Enquiry

Medicine Quality Alert: Class III Recall of Clindar B (Clindamycin 150mg) Capsules manufactured by Wallace Laboratories Pvt Ltd

The Globe Pharmacy Ltd is recalling batches CBL001CE & CBL002CE of Clindar B capsules due to crumbling and breaking of capsules

From: Pharmacy and Poisons Board

Published: 28th March 2023

Recall Reference Number: REC/2023/002

Recall Classification: Class III

Recall Level: Wholesaler/Distributor Level

Manufacturer: Wallace Laboratories Pvt Ltd, India

Local Technical Representative: Globe Pharmacy Ltd

Product name: Clindar B Capsules

Active Pharmaceutical Ingredient: Clindamycin 150mg

Affected Batches

 

Batch

Number

Date Of

Manufacture

Date Of Expiry

Pack Size

1.     

CBL001CE

21/05/2022

20/05/2025

100 capsules

2.     

CBL002CE

21/05/2022

20/05/2025

100 capsules

Brief description of the problem

Globe Pharmacy Ltd is recalling  CBL001CE & CBL002CE  batches of Clindar B capsules due to the crumbling and breaking of capsules, exposing the contents.

Action for healthcare professionals

Quarantine all remaining stock and stop further distribution, sale, issuing, and use of the affected batches immediately. You will be contacted by Globe Pharmacy Ltd to arrange for the return of the product.

Advice for patients and caregivers

No action is required for patients as this is a wholesaler/distributor level of recall. Patients should continue taking other batches of the product other than the impacted batches and as prescribed by the healthcare professional.

Further Information

For stock enquiries please contact Globe Pharmacy Ltd by email: globe@globe.co.ke or via telephone at +254 701 944 444, +254 775 444 555, +254 775 222 333

You are advised to promptly report any cases of adverse events and suspected substandard and falsified products to the nearest healthcare facility or through the following channels:

For any further information please contact the post-marketing surveillance unit at the Pharmacy and Poisons Board by email: pms@ppb.go.ke

Download document

Medicine Quality Alert: Class III Recall of Clindar B (Clindamycin 150mg)